| abstract |
The tumor therapeutic agent using the compound represented by the formula (I) or a pharmacologically acceptable salt thereof and the compound represented by the formula (II) in comparison with the case where each compound is used alone, Shows remarkable antitumor effect. [Wherein, R 1 represents a C 1-6 alkyl group or a C 3-8 cycloalkyl group, R 2 represents a hydrogen atom or a C 1-6 alkoxy group, and R 3 represents a hydrogen atom or a halogen atom. means. ] |